Mark Shlomchik

Ep. 31: “Autoimmune Diseases and B Cell Immunity” Featuring Dr. Mark Shlomchik Blog Post

Dr. Mark Shlomchik is a UPMC Endowed Distinguished Professor and Chair of the Department of Immunology at the University of Pittsburgh. He is also a Founder and Chief Scientific Officer of BlueSphere Bio, a company working to create individualized T cell therapies for the treatment of cancer. Dr. Shlomchik’s lab focuses on systemic autoimmune diseases, long-lived B cell immunity, and immunopathogenesis. He talks about the role of toll-like receptors in lupus, how his autoimmune disease research led to potential cancer therapies, and starting a biotech company with his brother.

Mark Shlomchik

Dr. Mark Shlomchik

Dr. Mark Shlomchik is a UPMC Endowed and Distinguished Professor and Chair of the Department of Immunology at the University of Pittsburgh. He is also a Founder and Chief Scientific…

Dr. Hanover Matz

Ep. 30: “Comparative Immunology and Sharks” Featuring Dr. Hanover Matz Blog Post

Dr. Hanover Matz is a Postdoctoral Fellow at the University of Maryland, who recently completed his PhD under the supervision of Dr. Helen Dooley. He discusses why sharks may have evolved adaptive immune systems, the role of T cells, mucosal immunity, and antibodies, and working with sharks in the lab.

Karen Edelblum

Dr. Karen Edelblum

Dr. Karen Edelblum is an Assistant Professor and Chancellor Scholar at the Center for Immunity and Inflammation at Rutgers New Jersey Medical School. Her lab studies immune/epithelial interactions to better understand…

Mark Kaplan

Dr. Mark Kaplan

Dr. Mark Kaplan is the Chair of the Department of Microbiology and Immunology at Indiana University School of Medicine. He is currently the Editor-In-Chief for the new American Association of…